Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Han Mian granules for pediatric adenoid hypertrophy (phase II, ultra–low-dose controlled)
CTR20260551Phase 2Active
- Sponsor
- Shandong Kangzhonghong Pharmaceutical Technology Development
- Start
- Apr 2026
- Countries
- 1
01
Overview
A Phase 2 trial of Hanmian Granules in adenoidal hypertrophy, sponsored by Shandong Kangzhonghong Pharmaceutical Technology Development. Started Apr 2026; status: active.
02
Drugs
Hanmian Granules
03
Conditions
adenoidal hypertrophy
Beyond the preview
Go deeper on CTR20260551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260551.